BioSpace News Archive

Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference on Monday, June 12, 2023, at 4:40pm (PT)/7:40pm (ET).

Telesis Bio Inc. announced it has signed a securities purchase agreement with a syndicate of healthcare-focused institutional investors that have agreed to provide initial upfront funding of $28.0 million in gross proceeds to Telesis Bio through a private placement of redeemable convertible preferred stock.

Santhera Pharmaceuticals announces the publication of its Annual Report 2022 with fully audited results for the year ended December 31, 2022.

Redwood Pharma AB (publ) announces positive results from the company’s clinical study with RP501, a medical technology self-care product being developed for the treatment of dry eye.

Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK) today announced the first subject has been dosed in a Phase 1 clinical trial evaluating BRII-297, a first-of-its-kind long-acting injectable (LAI), in development for the treatment of various anxiety and depressive disorders.

Antengene Corporation Limited announced that XPOVIO® in combination with bortezomib and dexamethasone is now listed on the PBS for the treatment of adult patients with R/R MM who have received at least one prior therapy.